PTEN’s tumour suppressor function was first characterized via its phosphoinositide phosphatase activity, whereby hydrolysis of PtdIns(3,4,5)P3 by PTEN directly opposes PI3K signalling activity [89–91]. The gene discussed is PIK3CA; the disease is neoplasm.